Patience is needed with this one , , hopefully it's only a few days and it will recover . people keep selling on sentiment only and no clear reason . Mayne is too big that's all what i know . once they can prove a +ve cash flow it will bounce back . they are adding products as they go like rhofade which add extra 15 m and so on -slowly building back
- Forums
- ASX - By Stock
- MYX
- Mayne Pharma sees strong sales growth in FY 2023
Mayne Pharma sees strong sales growth in FY 2023, page-62
Featured News
Add MYX (ASX) to my watchlist
(20min delay)
|
|||||
Last
$5.30 |
Change
0.100(1.92%) |
Mkt cap ! $450.8M |
Open | High | Low | Value | Volume |
$5.20 | $5.42 | $5.12 | $1.535M | 291.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 9999 | $5.30 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.37 | 760 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 9999 | 5.300 |
1 | 1468 | 5.290 |
1 | 760 | 5.270 |
1 | 760 | 5.260 |
1 | 760 | 5.240 |
Price($) | Vol. | No. |
---|---|---|
5.370 | 760 | 1 |
5.380 | 4975 | 4 |
5.390 | 760 | 1 |
5.410 | 760 | 1 |
5.420 | 960 | 2 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online